Jonathan I Lieber Salarius Pharmaceuticals, Inc. (SLRX) insider trading activity

SLRX Quotes by TradingView

Jonathan I Lieber is Director of Salarius Pharmaceuticals, Inc.. Currently has a direct ownership of 2,940 shares of SLRX, which is worth approximately $4,557. The most recent transaction as insider was on Jan 03, 2023, when has been sold 1,440 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.94K
0% 3M change
0% 12M change
Total Value Held $4,557

Jonathan I Lieber Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2023
BUY
Grant, award, or other acquisition
-
1,440 Added 32.88%
2,940 Common Stock
Jun 07 2022
BUY
Open market or private purchase
$7,125 $0.19 p/Share
37,500 Added 50.0%
37,500 Common Stock

Also insider at

AGTC
APPLIED GENETIC TECHNOLOGIES CORP Healthcare
Chief Financial Officer
RLYB
Rallybio Corp Healthcare
Chief Financial Officer
JIL

Jonathan I Lieber

Director
Alachua, FL

Track Institutional and Insider Activities on SLRX

Follow Salarius Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLRX shares.

Notify only if

Insider Trading

Get notified when an Salarius Pharmaceuticals, Inc. insider buys or sells SLRX shares.

Notify only if

News

Receive news related to Salarius Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SLRX